
Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Sara S. Nogueira is a scientist, RNA drug delivery, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.

Published: October 7th 2022 | Updated: